We can make a difference.
Virpax Pharmaceuticals is collaborating with the best research and development minds in the pharmaceutical industry. We are collaborating with these global drug development leaders, so we may improve how non-addictive pain medications and CNS disorder medications are delivered.
As part of our ongoing non-dilutive funding strategy, Virpax will pursue US and ex-US sublicensing and co-development opportunities with strategic partners in human and animal healthcare. We will also continue to seek government and military grants and cooperation agreements.
Partner with us as we develop and seek global approval for our next generation of non-addictive pain and CNS disorder product candidates.